Dear Friends and Colleagues, The “2020” is finally coming to an end, and almost for the last nine months (or more), we have been living with the new normals of the Covid-19 pandemic. These times for all of us, as well as for our families and friends, were highly stressful, challenging, fearsome, and unpredictable. Indisputably,…
News & Updates
Why do we need to go back to our routines?
A remarkable cover by @bmj_latest showing the direct and indirect impacts of Covid-19 and engaged interventions.. Time to consider going back to our normals (with caution)
Covid-19 has undone 25 years of global health progress in 25 weeks
“Mutually exacerbating catastrophes.” This is how the Bill and Melinda Gates’ Foundation describes Covid-19 and its knock-on effects, in its newly released report on the state of global health and development for 2020. That an organization typically of keen optimism, which has made it a mission to consistently highlight how the world has improved in the past…
Laws and regulations on M&A in Turkey
Very good source from first hand (Turkey investment office). All you need to know for an M&A activity in Turkey.. http://www.invest.gov.tr/en-US/infocenter/publications/Documents/MERGERS-ACQUISITIONS-TURKEY-GUIDE.pdf
UberX vs. Ambulance
Very interesting research topic – Did UberX reduce ambulance volume? – According to a paper by Moskatel and Slutsky (2019), the answer appears to be ‘yes’. Moskatel – 2019 – Health Economics – Wiley Online Library … #healtheconomics #uber #substitution #strategy #fiveforces #healthcare #UberX
Pharma companies got richer (at least for Q1 2019)
According to Axios’ post 12 of the most profitable drug companies in Q1 collectively reported more than $29 billion in profits. A majority of the health care industry’s profits in the first three months of 2019 went to the top 10 companies, and 9 of those 10 companies were pharmaceutical manufacturers, according to Axios’ quarterly analysis of…
“Beauty and the Beast” Turkey Pharmaceutical Market SWOT Final Part
And now it’s time to share Beauty and the Beast’s final version. To comprehend the Turkish Pharmaceutical Market potential completely, it might be valuable to review “opportunities and threads” together after ranking strengths and weaknesses of the industry individually. Turkey, with its refugee inflated >82MM population (TUIK/2018), has a statistically good potential vs. its peers among OECD countries with its current…